nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CALR—hematologic cancer	0.28	0.744	CbGaD
Melatonin—NQO2—Imatinib—hematologic cancer	0.0577	0.166	CbGbCtD
Melatonin—MPO—hematologic cancer	0.0551	0.146	CbGaD
Melatonin—ESR1—hematologic cancer	0.0413	0.11	CbGaD
Melatonin—CYP1B1—Procarbazine—hematologic cancer	0.0388	0.112	CbGbCtD
Melatonin—CYP1B1—Daunorubicin—hematologic cancer	0.0208	0.0598	CbGbCtD
Melatonin—CYP1B1—Dasatinib—hematologic cancer	0.0128	0.0368	CbGbCtD
Melatonin—CYP1B1—Mitoxantrone—hematologic cancer	0.0126	0.0363	CbGbCtD
Melatonin—MPO—Cisplatin—hematologic cancer	0.0122	0.0351	CbGbCtD
Melatonin—CYP1A2—Anagrelide—hematologic cancer	0.01	0.0288	CbGbCtD
Melatonin—CYP1A1—Methoxsalen—hematologic cancer	0.01	0.0288	CbGbCtD
Melatonin—CYP1A1—Bortezomib—hematologic cancer	0.00954	0.0274	CbGbCtD
Melatonin—CYP19A1—Betamethasone—hematologic cancer	0.00913	0.0263	CbGbCtD
Melatonin—CYP1A1—Daunorubicin—hematologic cancer	0.00912	0.0262	CbGbCtD
Melatonin—SLC22A8—Mercaptopurine—hematologic cancer	0.00889	0.0256	CbGbCtD
Melatonin—CYP1A1—Thalidomide—hematologic cancer	0.00831	0.0239	CbGbCtD
Melatonin—CYP1A1—Dacarbazine—hematologic cancer	0.00714	0.0205	CbGbCtD
Melatonin—CYP1B1—Dexamethasone—hematologic cancer	0.00655	0.0188	CbGbCtD
Melatonin—CYP2C9—Bexarotene—hematologic cancer	0.00626	0.018	CbGbCtD
Melatonin—CYP1A1—Dasatinib—hematologic cancer	0.00561	0.0161	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—hematologic cancer	0.00543	0.0156	CbGbCtD
Melatonin—CYP19A1—Dexamethasone—hematologic cancer	0.00531	0.0153	CbGbCtD
Melatonin—CYP1A2—Carmustine—hematologic cancer	0.00527	0.0152	CbGbCtD
Melatonin—CYP2C9—Idarubicin—hematologic cancer	0.00519	0.0149	CbGbCtD
Melatonin—CYP2C19—Bortezomib—hematologic cancer	0.00462	0.0133	CbGbCtD
Melatonin—CYP1A2—Methoxsalen—hematologic cancer	0.00448	0.0129	CbGbCtD
Melatonin—CYP1A2—Bortezomib—hematologic cancer	0.00426	0.0123	CbGbCtD
Melatonin—CYP1A2—Daunorubicin—hematologic cancer	0.00408	0.0117	CbGbCtD
Melatonin—CYP2C19—Thalidomide—hematologic cancer	0.00402	0.0116	CbGbCtD
Melatonin—CYP1A2—Alitretinoin—hematologic cancer	0.00399	0.0115	CbGbCtD
Melatonin—CYP2C9—Bortezomib—hematologic cancer	0.00384	0.011	CbGbCtD
Melatonin—CYP2C19—Teniposide—hematologic cancer	0.00384	0.011	CbGbCtD
Melatonin—CYP1A2—Thalidomide—hematologic cancer	0.00371	0.0107	CbGbCtD
Melatonin—CYP19A1—ovarian follicle—hematologic cancer	0.00367	0.0695	CbGeAlD
Melatonin—CYP2C19—Ifosfamide—hematologic cancer	0.00354	0.0102	CbGbCtD
Melatonin—CYP2C19—Imatinib—hematologic cancer	0.00338	0.00973	CbGbCtD
Melatonin—CYP2C9—Thalidomide—hematologic cancer	0.00334	0.00962	CbGbCtD
Melatonin—CYP1A2—Dacarbazine—hematologic cancer	0.00319	0.00918	CbGbCtD
Melatonin—CYP2C9—Teniposide—hematologic cancer	0.00319	0.00918	CbGbCtD
Melatonin—ESR1—ovarian follicle—hematologic cancer	0.00319	0.0604	CbGeAlD
Melatonin—CYP1A2—Imatinib—hematologic cancer	0.00312	0.00898	CbGbCtD
Melatonin—CYP2C9—Ifosfamide—hematologic cancer	0.00294	0.00847	CbGbCtD
Melatonin—SLC22A8—Methotrexate—hematologic cancer	0.00291	0.00836	CbGbCtD
Melatonin—CYP1A1—Dexamethasone—hematologic cancer	0.00287	0.00827	CbGbCtD
Melatonin—CYP2C9—Imatinib—hematologic cancer	0.00281	0.00809	CbGbCtD
Melatonin—EPX—hematopoietic system—hematologic cancer	0.00281	0.0533	CbGeAlD
Melatonin—CYP2C9—Nilotinib—hematologic cancer	0.00256	0.00735	CbGbCtD
Melatonin—CYP1A2—Dasatinib—hematologic cancer	0.00251	0.00721	CbGbCtD
Melatonin—CYP2C19—Prednisone—hematologic cancer	0.00223	0.00641	CbGbCtD
Melatonin—IDO1—hematopoietic system—hematologic cancer	0.00213	0.0404	CbGeAlD
Melatonin—MTNR1A—hematopoietic system—hematologic cancer	0.00189	0.0358	CbGeAlD
Melatonin—EPX—blood—hematologic cancer	0.00186	0.0353	CbGeAlD
Melatonin—EPX—bone marrow—hematologic cancer	0.0018	0.0341	CbGeAlD
Melatonin—ASMT—gonad—hematologic cancer	0.00177	0.0336	CbGeAlD
Melatonin—EPX—lung—hematologic cancer	0.00163	0.0309	CbGeAlD
Melatonin—CYP1A2—Etoposide—hematologic cancer	0.00156	0.00449	CbGbCtD
Melatonin—CYP2C9—Cisplatin—hematologic cancer	0.00143	0.00412	CbGbCtD
Melatonin—IDO1—blood—hematologic cancer	0.00141	0.0267	CbGeAlD
Melatonin—CYP2C19—Dexamethasone—hematologic cancer	0.00139	0.004	CbGbCtD
Melatonin—ASMT—testis—hematologic cancer	0.00128	0.0242	CbGeAlD
Melatonin—MTNR1A—blood—hematologic cancer	0.00125	0.0237	CbGeAlD
Melatonin—CALR—hematopoietic system—hematologic cancer	0.00125	0.0237	CbGeAlD
Melatonin—IDO1—lung—hematologic cancer	0.00124	0.0234	CbGeAlD
Melatonin—CYP2C9—Dexamethasone—hematologic cancer	0.00116	0.00333	CbGbCtD
Melatonin—MTNR1A—testis—hematologic cancer	0.00103	0.0196	CbGeAlD
Melatonin—CALR—gonad—hematologic cancer	0.000949	0.018	CbGeAlD
Melatonin—MT3—lung—hematologic cancer	0.000919	0.0174	CbGeAlD
Melatonin—MT3—testis—hematologic cancer	0.000867	0.0164	CbGeAlD
Melatonin—IDO1—lymph node—hematologic cancer	0.000846	0.016	CbGeAlD
Melatonin—CALR—blood—hematologic cancer	0.000827	0.0157	CbGeAlD
Melatonin—CALR—bone marrow—hematologic cancer	0.0008	0.0152	CbGeAlD
Melatonin—CALR—lung—hematologic cancer	0.000725	0.0137	CbGeAlD
Melatonin—CALR—testis—hematologic cancer	0.000684	0.013	CbGeAlD
Melatonin—MT3—lymph node—hematologic cancer	0.000628	0.0119	CbGeAlD
Melatonin—MPO—hematopoietic system—hematologic cancer	0.000542	0.0103	CbGeAlD
Melatonin—CALR—lymph node—hematologic cancer	0.000496	0.0094	CbGeAlD
Melatonin—Nabumetone—MPO—hematologic cancer	0.000472	0.619	CrCbGaD
Melatonin—NQO2—blood—hematologic cancer	0.000466	0.00884	CbGeAlD
Melatonin—NQO2—bone marrow—hematologic cancer	0.000451	0.00856	CbGeAlD
Melatonin—CYP19A1—hematopoietic system—hematologic cancer	0.000443	0.00839	CbGeAlD
Melatonin—SLC22A8—hematopoietic system—hematologic cancer	0.000433	0.00821	CbGeAlD
Melatonin—CYP1B1—hematopoietic system—hematologic cancer	0.000414	0.00785	CbGeAlD
Melatonin—NQO2—lung—hematologic cancer	0.000409	0.00775	CbGeAlD
Melatonin—NQO2—testis—hematologic cancer	0.000386	0.00731	CbGeAlD
Melatonin—ESR1—hematopoietic system—hematologic cancer	0.000385	0.00729	CbGeAlD
Melatonin—CALM2—hematopoietic system—hematologic cancer	0.000382	0.00725	CbGeAlD
Melatonin—CALM1—hematopoietic system—hematologic cancer	0.000381	0.00722	CbGeAlD
Melatonin—CYP2C19—hematopoietic system—hematologic cancer	0.000363	0.00689	CbGeAlD
Melatonin—MPO—blood—hematologic cancer	0.000359	0.00681	CbGeAlD
Melatonin—MPO—bone marrow—hematologic cancer	0.000347	0.00659	CbGeAlD
Melatonin—CYP19A1—gonad—hematologic cancer	0.000337	0.00638	CbGeAlD
Melatonin—CALM3—blood—hematologic cancer	0.000323	0.00612	CbGeAlD
Melatonin—CYP1B1—gonad—hematologic cancer	0.000315	0.00597	CbGeAlD
Melatonin—MPO—lung—hematologic cancer	0.000315	0.00597	CbGeAlD
Melatonin—CALM3—bone marrow—hematologic cancer	0.000312	0.00592	CbGeAlD
Melatonin—MPO—testis—hematologic cancer	0.000297	0.00563	CbGeAlD
Melatonin—CYP1A2—hematopoietic system—hematologic cancer	0.000297	0.00562	CbGeAlD
Melatonin—CYP19A1—blood—hematologic cancer	0.000293	0.00556	CbGeAlD
Melatonin—CYP1A1—hematopoietic system—hematologic cancer	0.000293	0.00555	CbGeAlD
Melatonin—ESR1—gonad—hematologic cancer	0.000293	0.00555	CbGeAlD
Melatonin—CALM2—gonad—hematologic cancer	0.000291	0.00551	CbGeAlD
Melatonin—CALM1—gonad—hematologic cancer	0.000289	0.00549	CbGeAlD
Melatonin—SLC22A8—blood—hematologic cancer	0.000287	0.00544	CbGeAlD
Melatonin—CALM3—lung—hematologic cancer	0.000283	0.00536	CbGeAlD
Melatonin—CYP2C9—hematopoietic system—hematologic cancer	0.000282	0.00534	CbGeAlD
Melatonin—NQO2—lymph node—hematologic cancer	0.00028	0.0053	CbGeAlD
Melatonin—CYP1B1—blood—hematologic cancer	0.000274	0.0052	CbGeAlD
Melatonin—CALM3—testis—hematologic cancer	0.000267	0.00506	CbGeAlD
Melatonin—ESR1—blood—hematologic cancer	0.000255	0.00483	CbGeAlD
Melatonin—CALM2—blood—hematologic cancer	0.000253	0.0048	CbGeAlD
Melatonin—CALM1—blood—hematologic cancer	0.000252	0.00478	CbGeAlD
Melatonin—CALM2—bone marrow—hematologic cancer	0.000245	0.00465	CbGeAlD
Melatonin—CALM1—bone marrow—hematologic cancer	0.000244	0.00463	CbGeAlD
Melatonin—CYP19A1—testis—hematologic cancer	0.000243	0.0046	CbGeAlD
Melatonin—CYP2C19—blood—hematologic cancer	0.000241	0.00456	CbGeAlD
Melatonin—CYP1B1—lung—hematologic cancer	0.00024	0.00456	CbGeAlD
Melatonin—CYP1B1—testis—hematologic cancer	0.000227	0.0043	CbGeAlD
Melatonin—ESR1—lung—hematologic cancer	0.000223	0.00424	CbGeAlD
Melatonin—CALM2—lung—hematologic cancer	0.000222	0.00421	CbGeAlD
Melatonin—CALM1—lung—hematologic cancer	0.000221	0.00419	CbGeAlD
Melatonin—MPO—lymph node—hematologic cancer	0.000215	0.00408	CbGeAlD
Melatonin—ESR1—testis—hematologic cancer	0.000211	0.004	CbGeAlD
Melatonin—CALM2—testis—hematologic cancer	0.00021	0.00397	CbGeAlD
Melatonin—CALM1—testis—hematologic cancer	0.000209	0.00396	CbGeAlD
Melatonin—Sumatriptan—ABCG2—hematologic cancer	0.000205	0.269	CrCbGaD
Melatonin—CYP1A2—blood—hematologic cancer	0.000197	0.00373	CbGeAlD
Melatonin—CYP1A1—blood—hematologic cancer	0.000194	0.00368	CbGeAlD
Melatonin—CALM3—lymph node—hematologic cancer	0.000193	0.00367	CbGeAlD
Melatonin—CYP2C9—blood—hematologic cancer	0.000187	0.00354	CbGeAlD
Melatonin—CYP19A1—lymph node—hematologic cancer	0.000176	0.00333	CbGeAlD
Melatonin—CYP1A2—lung—hematologic cancer	0.000172	0.00327	CbGeAlD
Melatonin—CYP1A1—lung—hematologic cancer	0.00017	0.00322	CbGeAlD
Melatonin—CYP1B1—lymph node—hematologic cancer	0.000164	0.00312	CbGeAlD
Melatonin—ESR1—lymph node—hematologic cancer	0.000153	0.0029	CbGeAlD
Melatonin—CALM2—lymph node—hematologic cancer	0.000152	0.00288	CbGeAlD
Melatonin—CALM1—lymph node—hematologic cancer	0.000151	0.00287	CbGeAlD
Melatonin—CYP1A1—lymph node—hematologic cancer	0.000116	0.0022	CbGeAlD
Melatonin—Sumatriptan—ABCB1—hematologic cancer	8.53e-05	0.112	CrCbGaD
Melatonin—Rash—Vincristine—hematologic cancer	2.01e-05	0.000165	CcSEcCtD
Melatonin—Dermatitis—Vincristine—hematologic cancer	2.01e-05	0.000165	CcSEcCtD
Melatonin—Pain—Triamcinolone—hematologic cancer	2e-05	0.000164	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—hematologic cancer	2e-05	0.000164	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—hematologic cancer	2e-05	0.000164	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—hematologic cancer	1.99e-05	0.000164	CcSEcCtD
Melatonin—Headache—Vincristine—hematologic cancer	1.99e-05	0.000164	CcSEcCtD
Melatonin—Loss of consciousness—Prednisone—hematologic cancer	1.99e-05	0.000163	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—hematologic cancer	1.98e-05	0.000163	CcSEcCtD
Melatonin—Nausea—Carmustine—hematologic cancer	1.98e-05	0.000163	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—hematologic cancer	1.97e-05	0.000162	CcSEcCtD
Melatonin—Vomiting—Mitoxantrone—hematologic cancer	1.97e-05	0.000162	CcSEcCtD
Melatonin—Vomiting—Irinotecan—hematologic cancer	1.97e-05	0.000162	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—hematologic cancer	1.96e-05	0.000161	CcSEcCtD
Melatonin—Nausea—Alitretinoin—hematologic cancer	1.96e-05	0.000161	CcSEcCtD
Melatonin—Hypertension—Prednisone—hematologic cancer	1.96e-05	0.000161	CcSEcCtD
Melatonin—Rash—Mitoxantrone—hematologic cancer	1.96e-05	0.000161	CcSEcCtD
Melatonin—Rash—Irinotecan—hematologic cancer	1.96e-05	0.000161	CcSEcCtD
Melatonin—Dermatitis—Mitoxantrone—hematologic cancer	1.95e-05	0.00016	CcSEcCtD
Melatonin—Dermatitis—Irinotecan—hematologic cancer	1.95e-05	0.00016	CcSEcCtD
Melatonin—Headache—Irinotecan—hematologic cancer	1.94e-05	0.00016	CcSEcCtD
Melatonin—Headache—Mitoxantrone—hematologic cancer	1.94e-05	0.00016	CcSEcCtD
Melatonin—Nausea—Ifosfamide—hematologic cancer	1.94e-05	0.000159	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.93e-05	0.000159	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.93e-05	0.000159	CcSEcCtD
Melatonin—Arthralgia—Prednisone—hematologic cancer	1.93e-05	0.000158	CcSEcCtD
Melatonin—Anxiety—Prednisone—hematologic cancer	1.92e-05	0.000158	CcSEcCtD
Melatonin—Vomiting—Gemcitabine—hematologic cancer	1.92e-05	0.000158	CcSEcCtD
Melatonin—Insomnia—Dexamethasone—hematologic cancer	1.92e-05	0.000158	CcSEcCtD
Melatonin—Insomnia—Betamethasone—hematologic cancer	1.92e-05	0.000158	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.92e-05	0.000157	CcSEcCtD
Melatonin—Paraesthesia—Betamethasone—hematologic cancer	1.91e-05	0.000157	CcSEcCtD
Melatonin—Paraesthesia—Dexamethasone—hematologic cancer	1.91e-05	0.000157	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—hematologic cancer	1.91e-05	0.000156	CcSEcCtD
Melatonin—Rash—Gemcitabine—hematologic cancer	1.9e-05	0.000156	CcSEcCtD
Melatonin—Dermatitis—Gemcitabine—hematologic cancer	1.9e-05	0.000156	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—hematologic cancer	1.9e-05	0.000156	CcSEcCtD
Melatonin—Hypersensitivity—Etoposide—hematologic cancer	1.9e-05	0.000156	CcSEcCtD
Melatonin—Erythema—Methotrexate—hematologic cancer	1.89e-05	0.000155	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—hematologic cancer	1.89e-05	0.000155	CcSEcCtD
Melatonin—Headache—Gemcitabine—hematologic cancer	1.89e-05	0.000155	CcSEcCtD
Melatonin—Nausea—Vincristine—hematologic cancer	1.89e-05	0.000155	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—hematologic cancer	1.89e-05	0.000155	CcSEcCtD
Melatonin—Hypersensitivity—Prednisolone—hematologic cancer	1.87e-05	0.000154	CcSEcCtD
Melatonin—Dyspepsia—Dexamethasone—hematologic cancer	1.87e-05	0.000153	CcSEcCtD
Melatonin—Dyspepsia—Betamethasone—hematologic cancer	1.87e-05	0.000153	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—hematologic cancer	1.86e-05	0.000153	CcSEcCtD
Melatonin—Asthenia—Etoposide—hematologic cancer	1.85e-05	0.000152	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—hematologic cancer	1.85e-05	0.000152	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—hematologic cancer	1.85e-05	0.000152	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—hematologic cancer	1.85e-05	0.000152	CcSEcCtD
Melatonin—Nausea—Mitoxantrone—hematologic cancer	1.84e-05	0.000151	CcSEcCtD
Melatonin—Nausea—Irinotecan—hematologic cancer	1.84e-05	0.000151	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—hematologic cancer	1.84e-05	0.000151	CcSEcCtD
Melatonin—Infection—Prednisone—hematologic cancer	1.84e-05	0.000151	CcSEcCtD
Melatonin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.83e-05	0.00015	CcSEcCtD
Melatonin—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.83e-05	0.00015	CcSEcCtD
Melatonin—Back pain—Methotrexate—hematologic cancer	1.83e-05	0.00015	CcSEcCtD
Melatonin—Fatigue—Dexamethasone—hematologic cancer	1.83e-05	0.00015	CcSEcCtD
Melatonin—Fatigue—Betamethasone—hematologic cancer	1.83e-05	0.00015	CcSEcCtD
Melatonin—Pruritus—Etoposide—hematologic cancer	1.82e-05	0.00015	CcSEcCtD
Melatonin—Shock—Prednisone—hematologic cancer	1.82e-05	0.000149	CcSEcCtD
Melatonin—Pain—Betamethasone—hematologic cancer	1.82e-05	0.000149	CcSEcCtD
Melatonin—Pain—Dexamethasone—hematologic cancer	1.82e-05	0.000149	CcSEcCtD
Melatonin—Nervous system disorder—Prednisone—hematologic cancer	1.81e-05	0.000149	CcSEcCtD
Melatonin—Skin disorder—Prednisone—hematologic cancer	1.8e-05	0.000147	CcSEcCtD
Melatonin—Nausea—Gemcitabine—hematologic cancer	1.79e-05	0.000147	CcSEcCtD
Melatonin—Vomiting—Cisplatin—hematologic cancer	1.79e-05	0.000147	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—hematologic cancer	1.78e-05	0.000147	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—hematologic cancer	1.78e-05	0.000146	CcSEcCtD
Melatonin—Rash—Cisplatin—hematologic cancer	1.78e-05	0.000146	CcSEcCtD
Melatonin—Dermatitis—Cisplatin—hematologic cancer	1.77e-05	0.000146	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—hematologic cancer	1.77e-05	0.000145	CcSEcCtD
Melatonin—Erythema—Epirubicin—hematologic cancer	1.77e-05	0.000145	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—hematologic cancer	1.76e-05	0.000145	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—hematologic cancer	1.75e-05	0.000144	CcSEcCtD
Melatonin—Flatulence—Epirubicin—hematologic cancer	1.75e-05	0.000143	CcSEcCtD
Melatonin—Tension—Epirubicin—hematologic cancer	1.74e-05	0.000143	CcSEcCtD
Melatonin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.74e-05	0.000143	CcSEcCtD
Melatonin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.74e-05	0.000143	CcSEcCtD
Melatonin—Hypersensitivity—Triamcinolone—hematologic cancer	1.72e-05	0.000142	CcSEcCtD
Melatonin—Nervousness—Epirubicin—hematologic cancer	1.72e-05	0.000141	CcSEcCtD
Melatonin—Back pain—Epirubicin—hematologic cancer	1.71e-05	0.000141	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—hematologic cancer	1.71e-05	0.00014	CcSEcCtD
Melatonin—Dizziness—Etoposide—hematologic cancer	1.71e-05	0.00014	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—hematologic cancer	1.7e-05	0.00014	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—hematologic cancer	1.7e-05	0.00014	CcSEcCtD
Melatonin—Vertigo—Methotrexate—hematologic cancer	1.7e-05	0.00014	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—hematologic cancer	1.69e-05	0.000139	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.68e-05	0.000138	CcSEcCtD
Melatonin—Dizziness—Prednisolone—hematologic cancer	1.68e-05	0.000138	CcSEcCtD
Melatonin—Asthenia—Triamcinolone—hematologic cancer	1.68e-05	0.000138	CcSEcCtD
Melatonin—Abdominal pain—Dexamethasone—hematologic cancer	1.68e-05	0.000138	CcSEcCtD
Melatonin—Abdominal pain—Betamethasone—hematologic cancer	1.68e-05	0.000138	CcSEcCtD
Melatonin—Nausea—Cisplatin—hematologic cancer	1.67e-05	0.000137	CcSEcCtD
Melatonin—Insomnia—Prednisone—hematologic cancer	1.67e-05	0.000137	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—hematologic cancer	1.67e-05	0.000137	CcSEcCtD
Melatonin—Paraesthesia—Prednisone—hematologic cancer	1.66e-05	0.000136	CcSEcCtD
Melatonin—Pruritus—Triamcinolone—hematologic cancer	1.66e-05	0.000136	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—hematologic cancer	1.65e-05	0.000135	CcSEcCtD
Melatonin—Vomiting—Etoposide—hematologic cancer	1.64e-05	0.000135	CcSEcCtD
Melatonin—Erythema—Doxorubicin—hematologic cancer	1.64e-05	0.000135	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—hematologic cancer	1.64e-05	0.000135	CcSEcCtD
Melatonin—Agitation—Epirubicin—hematologic cancer	1.63e-05	0.000134	CcSEcCtD
Melatonin—Dyspepsia—Prednisone—hematologic cancer	1.63e-05	0.000134	CcSEcCtD
Melatonin—Rash—Etoposide—hematologic cancer	1.63e-05	0.000134	CcSEcCtD
Melatonin—Dermatitis—Etoposide—hematologic cancer	1.62e-05	0.000133	CcSEcCtD
Melatonin—Headache—Etoposide—hematologic cancer	1.62e-05	0.000133	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—hematologic cancer	1.62e-05	0.000133	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—hematologic cancer	1.61e-05	0.000132	CcSEcCtD
Melatonin—Chest pain—Methotrexate—hematologic cancer	1.61e-05	0.000132	CcSEcCtD
Melatonin—Tension—Doxorubicin—hematologic cancer	1.61e-05	0.000132	CcSEcCtD
Melatonin—Rash—Prednisolone—hematologic cancer	1.6e-05	0.000132	CcSEcCtD
Melatonin—Dermatitis—Prednisolone—hematologic cancer	1.6e-05	0.000132	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.6e-05	0.000131	CcSEcCtD
Melatonin—Fatigue—Prednisone—hematologic cancer	1.59e-05	0.000131	CcSEcCtD
Melatonin—Headache—Prednisolone—hematologic cancer	1.59e-05	0.000131	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—hematologic cancer	1.59e-05	0.000131	CcSEcCtD
Melatonin—Vertigo—Epirubicin—hematologic cancer	1.59e-05	0.000131	CcSEcCtD
Melatonin—Syncope—Epirubicin—hematologic cancer	1.59e-05	0.00013	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—hematologic cancer	1.59e-05	0.00013	CcSEcCtD
Melatonin—Back pain—Doxorubicin—hematologic cancer	1.59e-05	0.00013	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—hematologic cancer	1.58e-05	0.000129	CcSEcCtD
Melatonin—Palpitations—Epirubicin—hematologic cancer	1.57e-05	0.000129	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—hematologic cancer	1.56e-05	0.000128	CcSEcCtD
Melatonin—Dizziness—Triamcinolone—hematologic cancer	1.55e-05	0.000127	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—hematologic cancer	1.54e-05	0.000127	CcSEcCtD
Melatonin—Infection—Methotrexate—hematologic cancer	1.53e-05	0.000126	CcSEcCtD
Melatonin—Nausea—Etoposide—hematologic cancer	1.53e-05	0.000126	CcSEcCtD
Melatonin—Hypertension—Epirubicin—hematologic cancer	1.53e-05	0.000126	CcSEcCtD
Melatonin—Asthenia—Dexamethasone—hematologic cancer	1.52e-05	0.000125	CcSEcCtD
Melatonin—Asthenia—Betamethasone—hematologic cancer	1.52e-05	0.000125	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—hematologic cancer	1.52e-05	0.000124	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—hematologic cancer	1.51e-05	0.000124	CcSEcCtD
Melatonin—Gastrointestinal pain—Prednisone—hematologic cancer	1.51e-05	0.000124	CcSEcCtD
Melatonin—Nausea—Prednisolone—hematologic cancer	1.51e-05	0.000124	CcSEcCtD
Melatonin—Chest pain—Epirubicin—hematologic cancer	1.51e-05	0.000124	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—hematologic cancer	1.51e-05	0.000124	CcSEcCtD
Melatonin—Agitation—Doxorubicin—hematologic cancer	1.51e-05	0.000124	CcSEcCtD
Melatonin—Anxiety—Epirubicin—hematologic cancer	1.5e-05	0.000123	CcSEcCtD
Melatonin—Pruritus—Dexamethasone—hematologic cancer	1.5e-05	0.000123	CcSEcCtD
Melatonin—Pruritus—Betamethasone—hematologic cancer	1.5e-05	0.000123	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—hematologic cancer	1.5e-05	0.000123	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.5e-05	0.000123	CcSEcCtD
Melatonin—Vomiting—Triamcinolone—hematologic cancer	1.49e-05	0.000122	CcSEcCtD
Melatonin—Rash—Triamcinolone—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Melatonin—Dermatitis—Triamcinolone—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Melatonin—Syncope—Doxorubicin—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—hematologic cancer	1.47e-05	0.00012	CcSEcCtD
Melatonin—Headache—Triamcinolone—hematologic cancer	1.47e-05	0.00012	CcSEcCtD
Melatonin—Abdominal pain—Prednisone—hematologic cancer	1.46e-05	0.00012	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—hematologic cancer	1.45e-05	0.000119	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—hematologic cancer	1.44e-05	0.000118	CcSEcCtD
Melatonin—Infection—Epirubicin—hematologic cancer	1.44e-05	0.000118	CcSEcCtD
Melatonin—Shock—Epirubicin—hematologic cancer	1.42e-05	0.000117	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—hematologic cancer	1.42e-05	0.000116	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—hematologic cancer	1.42e-05	0.000116	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—hematologic cancer	1.42e-05	0.000116	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.41e-05	0.000116	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—hematologic cancer	1.4e-05	0.000115	CcSEcCtD
Melatonin—Dizziness—Dexamethasone—hematologic cancer	1.4e-05	0.000115	CcSEcCtD
Melatonin—Dizziness—Betamethasone—hematologic cancer	1.4e-05	0.000115	CcSEcCtD
Melatonin—Insomnia—Methotrexate—hematologic cancer	1.4e-05	0.000115	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—hematologic cancer	1.4e-05	0.000115	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—hematologic cancer	1.4e-05	0.000115	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—hematologic cancer	1.39e-05	0.000114	CcSEcCtD
Melatonin—Nausea—Triamcinolone—hematologic cancer	1.39e-05	0.000114	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—hematologic cancer	1.39e-05	0.000114	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.39e-05	0.000114	CcSEcCtD
Melatonin—Somnolence—Methotrexate—hematologic cancer	1.37e-05	0.000113	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—hematologic cancer	1.36e-05	0.000112	CcSEcCtD
Melatonin—Hypersensitivity—Prednisone—hematologic cancer	1.36e-05	0.000112	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—hematologic cancer	1.36e-05	0.000112	CcSEcCtD
Melatonin—Vomiting—Dexamethasone—hematologic cancer	1.35e-05	0.000111	CcSEcCtD
Melatonin—Vomiting—Betamethasone—hematologic cancer	1.35e-05	0.000111	CcSEcCtD
Melatonin—Rash—Betamethasone—hematologic cancer	1.34e-05	0.00011	CcSEcCtD
Melatonin—Rash—Dexamethasone—hematologic cancer	1.34e-05	0.00011	CcSEcCtD
Melatonin—Dermatitis—Betamethasone—hematologic cancer	1.34e-05	0.00011	CcSEcCtD
Melatonin—Dermatitis—Dexamethasone—hematologic cancer	1.34e-05	0.00011	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.33e-05	0.00011	CcSEcCtD
Melatonin—Fatigue—Methotrexate—hematologic cancer	1.33e-05	0.000109	CcSEcCtD
Melatonin—Headache—Betamethasone—hematologic cancer	1.33e-05	0.000109	CcSEcCtD
Melatonin—Headache—Dexamethasone—hematologic cancer	1.33e-05	0.000109	CcSEcCtD
Melatonin—Infection—Doxorubicin—hematologic cancer	1.33e-05	0.000109	CcSEcCtD
Melatonin—Asthenia—Prednisone—hematologic cancer	1.33e-05	0.000109	CcSEcCtD
Melatonin—Pain—Methotrexate—hematologic cancer	1.32e-05	0.000108	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.32e-05	0.000108	CcSEcCtD
Melatonin—Shock—Doxorubicin—hematologic cancer	1.32e-05	0.000108	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—hematologic cancer	1.31e-05	0.000108	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.31e-05	0.000108	CcSEcCtD
Melatonin—Pruritus—Prednisone—hematologic cancer	1.31e-05	0.000107	CcSEcCtD
Melatonin—Insomnia—Epirubicin—hematologic cancer	1.31e-05	0.000107	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—hematologic cancer	1.3e-05	0.000107	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—hematologic cancer	1.3e-05	0.000107	CcSEcCtD
Melatonin—Somnolence—Epirubicin—hematologic cancer	1.29e-05	0.000106	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—hematologic cancer	1.27e-05	0.000105	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.26e-05	0.000104	CcSEcCtD
Melatonin—Nausea—Dexamethasone—hematologic cancer	1.26e-05	0.000104	CcSEcCtD
Melatonin—Nausea—Betamethasone—hematologic cancer	1.26e-05	0.000104	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.25e-05	0.000103	CcSEcCtD
Melatonin—Fatigue—Epirubicin—hematologic cancer	1.25e-05	0.000102	CcSEcCtD
Melatonin—Pain—Epirubicin—hematologic cancer	1.24e-05	0.000102	CcSEcCtD
Melatonin—Dizziness—Prednisone—hematologic cancer	1.22e-05	0.0001	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—hematologic cancer	1.22e-05	0.0001	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.22e-05	0.0001	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—hematologic cancer	1.21e-05	9.94e-05	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—hematologic cancer	1.2e-05	9.86e-05	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—hematologic cancer	1.19e-05	9.77e-05	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.18e-05	9.71e-05	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—hematologic cancer	1.18e-05	9.67e-05	CcSEcCtD
Melatonin—Vomiting—Prednisone—hematologic cancer	1.18e-05	9.65e-05	CcSEcCtD
Melatonin—Rash—Prednisone—hematologic cancer	1.17e-05	9.57e-05	CcSEcCtD
Melatonin—Dermatitis—Prednisone—hematologic cancer	1.16e-05	9.56e-05	CcSEcCtD
Melatonin—Headache—Prednisone—hematologic cancer	1.16e-05	9.51e-05	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.15e-05	9.48e-05	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—hematologic cancer	1.15e-05	9.47e-05	CcSEcCtD
Melatonin—Pain—Doxorubicin—hematologic cancer	1.14e-05	9.39e-05	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—hematologic cancer	1.14e-05	9.39e-05	CcSEcCtD
Melatonin—Hypersensitivity—Methotrexate—hematologic cancer	1.14e-05	9.35e-05	CcSEcCtD
Melatonin—Asthenia—Methotrexate—hematologic cancer	1.11e-05	9.1e-05	CcSEcCtD
Melatonin—Nausea—Prednisone—hematologic cancer	1.1e-05	9.02e-05	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.09e-05	8.98e-05	CcSEcCtD
Melatonin—Pruritus—Methotrexate—hematologic cancer	1.09e-05	8.98e-05	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—hematologic cancer	1.07e-05	8.75e-05	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—hematologic cancer	1.06e-05	8.68e-05	CcSEcCtD
Melatonin—Asthenia—Epirubicin—hematologic cancer	1.04e-05	8.52e-05	CcSEcCtD
Melatonin—Pruritus—Epirubicin—hematologic cancer	1.02e-05	8.4e-05	CcSEcCtD
Melatonin—Dizziness—Methotrexate—hematologic cancer	1.02e-05	8.39e-05	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—hematologic cancer	9.86e-06	8.09e-05	CcSEcCtD
Melatonin—Vomiting—Methotrexate—hematologic cancer	9.82e-06	8.07e-05	CcSEcCtD
Melatonin—Rash—Methotrexate—hematologic cancer	9.74e-06	8e-05	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—hematologic cancer	9.73e-06	7.99e-05	CcSEcCtD
Melatonin—Headache—Methotrexate—hematologic cancer	9.68e-06	7.95e-05	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—hematologic cancer	9.6e-06	7.88e-05	CcSEcCtD
Melatonin—Dizziness—Epirubicin—hematologic cancer	9.56e-06	7.85e-05	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—hematologic cancer	9.46e-06	7.77e-05	CcSEcCtD
Melatonin—Vomiting—Epirubicin—hematologic cancer	9.19e-06	7.55e-05	CcSEcCtD
Melatonin—Nausea—Methotrexate—hematologic cancer	9.18e-06	7.54e-05	CcSEcCtD
Melatonin—Rash—Epirubicin—hematologic cancer	9.12e-06	7.49e-05	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—hematologic cancer	9.11e-06	7.48e-05	CcSEcCtD
Melatonin—Headache—Epirubicin—hematologic cancer	9.06e-06	7.44e-05	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—hematologic cancer	8.85e-06	7.26e-05	CcSEcCtD
Melatonin—Nausea—Epirubicin—hematologic cancer	8.59e-06	7.05e-05	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—hematologic cancer	8.51e-06	6.98e-05	CcSEcCtD
Melatonin—Rash—Doxorubicin—hematologic cancer	8.43e-06	6.93e-05	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—hematologic cancer	8.43e-06	6.92e-05	CcSEcCtD
Melatonin—Headache—Doxorubicin—hematologic cancer	8.38e-06	6.88e-05	CcSEcCtD
Melatonin—Nausea—Doxorubicin—hematologic cancer	7.95e-06	6.53e-05	CcSEcCtD
Melatonin—CALM1—Immune System—SRC—hematologic cancer	6.31e-07	6.3e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—SRC—hematologic cancer	6.31e-07	6.3e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1A—hematologic cancer	6.3e-07	6.29e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1A—hematologic cancer	6.3e-07	6.29e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CB—hematologic cancer	6.3e-07	6.28e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—hematologic cancer	6.29e-07	6.28e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—hematologic cancer	6.28e-07	6.27e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—hematologic cancer	6.28e-07	6.27e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRAS—hematologic cancer	6.28e-07	6.27e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—hematologic cancer	6.25e-07	6.24e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—hematologic cancer	6.25e-07	6.24e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EP300—hematologic cancer	6.21e-07	6.2e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—EP300—hematologic cancer	6.2e-07	6.18e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCL2—hematologic cancer	6.19e-07	6.18e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCL2—hematologic cancer	6.19e-07	6.18e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6R—hematologic cancer	6.17e-07	6.16e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6R—hematologic cancer	6.17e-07	6.16e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CREBBP—hematologic cancer	6.16e-07	6.15e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CREBBP—hematologic cancer	6.16e-07	6.15e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—hematologic cancer	6.14e-07	6.13e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.1e-07	6.09e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CB—hematologic cancer	6.09e-07	6.08e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CB—hematologic cancer	6.09e-07	6.08e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—hematologic cancer	6.09e-07	6.08e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—hematologic cancer	6.09e-07	6.08e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAP2K1—hematologic cancer	6.08e-07	6.07e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—hematologic cancer	6.07e-07	6.06e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—hematologic cancer	6.07e-07	6.06e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SRC—hematologic cancer	6.04e-07	6.03e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CD—hematologic cancer	6.04e-07	6.03e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—SRC—hematologic cancer	6.02e-07	6.01e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK3—hematologic cancer	6.01e-07	6e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—EP300—hematologic cancer	5.99e-07	5.98e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—EP300—hematologic cancer	5.99e-07	5.98e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CB—hematologic cancer	5.97e-07	5.96e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—MTHFR—hematologic cancer	5.92e-07	5.91e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CREBBP—hematologic cancer	5.92e-07	5.9e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—hematologic cancer	5.91e-07	5.9e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—hematologic cancer	5.91e-07	5.9e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—hematologic cancer	5.89e-07	5.87e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAP2K1—hematologic cancer	5.88e-07	5.87e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAP2K1—hematologic cancer	5.88e-07	5.87e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CD—hematologic cancer	5.84e-07	5.83e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CD—hematologic cancer	5.84e-07	5.83e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—SRC—hematologic cancer	5.83e-07	5.82e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—SRC—hematologic cancer	5.83e-07	5.82e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—hematologic cancer	5.83e-07	5.82e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	5.82e-07	5.81e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK3—hematologic cancer	5.82e-07	5.8e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK3—hematologic cancer	5.82e-07	5.8e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—hematologic cancer	5.81e-07	5.8e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—hematologic cancer	5.81e-07	5.8e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—hematologic cancer	5.8e-07	5.78e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FGF2—hematologic cancer	5.78e-07	5.77e-06	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—hematologic cancer	5.78e-07	5.76e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—hematologic cancer	5.72e-07	5.71e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—hematologic cancer	5.72e-07	5.71e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3R1—hematologic cancer	5.7e-07	5.69e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—hematologic cancer	5.62e-07	5.61e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—hematologic cancer	5.62e-07	5.61e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CD—hematologic cancer	5.61e-07	5.6e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—hematologic cancer	5.61e-07	5.6e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—hematologic cancer	5.61e-07	5.6e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FGF2—hematologic cancer	5.59e-07	5.58e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FGF2—hematologic cancer	5.59e-07	5.58e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK3—hematologic cancer	5.57e-07	5.56e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK3—hematologic cancer	5.55e-07	5.54e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JAK2—hematologic cancer	5.54e-07	5.53e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ALB—hematologic cancer	5.54e-07	5.53e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3R1—hematologic cancer	5.52e-07	5.51e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3R1—hematologic cancer	5.52e-07	5.51e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—hematologic cancer	5.44e-07	5.43e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—hematologic cancer	5.43e-07	5.42e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—hematologic cancer	5.42e-07	5.4e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MDM2—hematologic cancer	5.41e-07	5.4e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—hematologic cancer	5.4e-07	5.39e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFB1—hematologic cancer	5.4e-07	5.39e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—hematologic cancer	5.4e-07	5.39e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CREBBP—hematologic cancer	5.39e-07	5.38e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFB1—hematologic cancer	5.39e-07	5.38e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK3—hematologic cancer	5.37e-07	5.36e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK3—hematologic cancer	5.37e-07	5.36e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JAK2—hematologic cancer	5.36e-07	5.35e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JAK2—hematologic cancer	5.36e-07	5.35e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3R1—hematologic cancer	5.3e-07	5.29e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CB—hematologic cancer	5.26e-07	5.25e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MTOR—hematologic cancer	5.26e-07	5.25e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—hematologic cancer	5.26e-07	5.25e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—hematologic cancer	5.26e-07	5.25e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—hematologic cancer	5.26e-07	5.25e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—hematologic cancer	5.26e-07	5.25e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MDM2—hematologic cancer	5.23e-07	5.22e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MDM2—hematologic cancer	5.23e-07	5.22e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—hematologic cancer	5.23e-07	5.22e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—hematologic cancer	5.23e-07	5.22e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—hematologic cancer	5.22e-07	5.21e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—hematologic cancer	5.22e-07	5.21e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.21e-07	5.2e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFB1—hematologic cancer	5.21e-07	5.2e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFB1—hematologic cancer	5.21e-07	5.2e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—EP300—hematologic cancer	5.19e-07	5.18e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—hematologic cancer	5.16e-07	5.15e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	5.11e-07	5.1e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	5.09e-07	5.08e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MTOR—hematologic cancer	5.09e-07	5.08e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	5.09e-07	5.08e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MTOR—hematologic cancer	5.09e-07	5.08e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ALB—hematologic cancer	5.05e-07	5.04e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—hematologic cancer	5.03e-07	5.02e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—EP300—hematologic cancer	5.02e-07	5.01e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—EP300—hematologic cancer	5.02e-07	5.01e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—hematologic cancer	5.02e-07	5.01e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—hematologic cancer	5e-07	4.99e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—hematologic cancer	4.99e-07	4.98e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	4.97e-07	4.96e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—hematologic cancer	4.96e-07	4.95e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	4.94e-07	4.93e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—EP300—hematologic cancer	4.92e-07	4.91e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CB—hematologic cancer	4.89e-07	4.88e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—hematologic cancer	4.86e-07	4.85e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—hematologic cancer	4.86e-07	4.85e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—hematologic cancer	4.84e-07	4.83e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—hematologic cancer	4.83e-07	4.83e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—hematologic cancer	4.83e-07	4.82e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.83e-07	4.82e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—hematologic cancer	4.83e-07	4.82e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—hematologic cancer	4.83e-07	4.82e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—hematologic cancer	4.81e-07	4.8e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—hematologic cancer	4.8e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—hematologic cancer	4.8e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	4.78e-07	4.77e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	4.78e-07	4.77e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—hematologic cancer	4.71e-07	4.7e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JUN—hematologic cancer	4.7e-07	4.69e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—hematologic cancer	4.68e-07	4.68e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—hematologic cancer	4.68e-07	4.68e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—hematologic cancer	4.68e-07	4.67e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—hematologic cancer	4.68e-07	4.67e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—hematologic cancer	4.65e-07	4.64e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—hematologic cancer	4.65e-07	4.64e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CREBBP—hematologic cancer	4.61e-07	4.6e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	4.6e-07	4.59e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—hematologic cancer	4.59e-07	4.58e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—hematologic cancer	4.58e-07	4.57e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	4.56e-07	4.55e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—hematologic cancer	4.56e-07	4.55e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—hematologic cancer	4.56e-07	4.55e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JUN—hematologic cancer	4.55e-07	4.54e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JUN—hematologic cancer	4.55e-07	4.54e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—hematologic cancer	4.55e-07	4.54e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	4.46e-07	4.45e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK8—hematologic cancer	4.45e-07	4.44e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—hematologic cancer	4.45e-07	4.44e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—hematologic cancer	4.44e-07	4.43e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—hematologic cancer	4.44e-07	4.43e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—hematologic cancer	4.44e-07	4.43e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—hematologic cancer	4.43e-07	4.42e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—hematologic cancer	4.43e-07	4.42e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	4.41e-07	4.4e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	4.41e-07	4.4e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—hematologic cancer	4.4e-07	4.39e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—hematologic cancer	4.4e-07	4.39e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—hematologic cancer	4.4e-07	4.39e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	4.37e-07	4.36e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EP300—hematologic cancer	4.34e-07	4.33e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ALB—hematologic cancer	4.31e-07	4.31e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK8—hematologic cancer	4.3e-07	4.3e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK8—hematologic cancer	4.3e-07	4.3e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—hematologic cancer	4.29e-07	4.28e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—hematologic cancer	4.29e-07	4.28e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—hematologic cancer	4.25e-07	4.24e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—hematologic cancer	4.25e-07	4.24e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—hematologic cancer	4.25e-07	4.24e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—hematologic cancer	4.24e-07	4.23e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—hematologic cancer	4.22e-07	4.22e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SRC—hematologic cancer	4.22e-07	4.21e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EP300—hematologic cancer	4.2e-07	4.19e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EP300—hematologic cancer	4.2e-07	4.19e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	4.13e-07	4.12e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—hematologic cancer	4.11e-07	4.1e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—hematologic cancer	4.1e-07	4.09e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—hematologic cancer	4.1e-07	4.09e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SRC—hematologic cancer	4.08e-07	4.07e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SRC—hematologic cancer	4.08e-07	4.07e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—hematologic cancer	4.07e-07	4.06e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—hematologic cancer	4.07e-07	4.06e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—hematologic cancer	4.06e-07	4.05e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—hematologic cancer	4.06e-07	4.05e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—hematologic cancer	4.05e-07	4.05e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—EP300—hematologic cancer	4.03e-07	4.02e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—hematologic cancer	3.97e-07	3.97e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—hematologic cancer	3.97e-07	3.97e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—hematologic cancer	3.94e-07	3.93e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—hematologic cancer	3.94e-07	3.93e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—hematologic cancer	3.93e-07	3.92e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—hematologic cancer	3.93e-07	3.92e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—hematologic cancer	3.93e-07	3.92e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—hematologic cancer	3.93e-07	3.92e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—hematologic cancer	3.92e-07	3.92e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—hematologic cancer	3.92e-07	3.92e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK3—hematologic cancer	3.89e-07	3.88e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—hematologic cancer	3.85e-07	3.84e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—hematologic cancer	3.84e-07	3.83e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	3.81e-07	3.8e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—hematologic cancer	3.78e-07	3.77e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFB1—hematologic cancer	3.77e-07	3.76e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK3—hematologic cancer	3.76e-07	3.75e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK3—hematologic cancer	3.76e-07	3.75e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—hematologic cancer	3.76e-07	3.75e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—hematologic cancer	3.74e-07	3.74e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—hematologic cancer	3.71e-07	3.71e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—hematologic cancer	3.71e-07	3.71e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—EP300—hematologic cancer	3.67e-07	3.67e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—hematologic cancer	3.66e-07	3.65e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—hematologic cancer	3.66e-07	3.65e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFB1—hematologic cancer	3.65e-07	3.64e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFB1—hematologic cancer	3.65e-07	3.64e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—hematologic cancer	3.64e-07	3.63e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—hematologic cancer	3.62e-07	3.61e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—hematologic cancer	3.62e-07	3.61e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—hematologic cancer	3.49e-07	3.49e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—hematologic cancer	3.38e-07	3.37e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—hematologic cancer	3.38e-07	3.37e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—hematologic cancer	3.29e-07	3.29e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	3.21e-07	3.2e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—EP300—hematologic cancer	3.14e-07	3.13e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—hematologic cancer	3.14e-07	3.13e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—hematologic cancer	3.1e-07	3.1e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	3.1e-07	3.1e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	3.1e-07	3.1e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—hematologic cancer	3.03e-07	3.03e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—hematologic cancer	3.03e-07	3.03e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—hematologic cancer	3e-07	3e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—hematologic cancer	3e-07	3e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.98e-07	2.97e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—hematologic cancer	2.97e-07	2.97e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—hematologic cancer	2.97e-07	2.96e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—hematologic cancer	2.87e-07	2.87e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—hematologic cancer	2.87e-07	2.87e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—hematologic cancer	2.84e-07	2.84e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—hematologic cancer	2.75e-07	2.74e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—hematologic cancer	2.75e-07	2.74e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.72e-07	2.71e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—hematologic cancer	2.62e-07	2.62e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—hematologic cancer	2.54e-07	2.53e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—hematologic cancer	2.54e-07	2.53e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—hematologic cancer	2.43e-07	2.43e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.32e-07	2.32e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—hematologic cancer	2.22e-07	2.22e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—hematologic cancer	1.9e-07	1.89e-06	CbGpPWpGaD
